Return to Course LibraryCE InformationPrint Course MaterialsBibliographyGlossaryRegister Now

Release Date:
May 11, 2017

Expiration Date:
May 31, 2019





Bonnie Rush, RT(R)(M)(QM)
Breast Imaging Specialists
MQSA Made Easy



Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0

A Critical Mammography Inspection Update


A free certified one-hour pre-recorded webinar for Breast Center Directors, Lead Interpreting Physicians, Interpreting Physicians, and Radiologic Technologists

Recording of a live webinar presented on April 25, 2017

Format: Archived  Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A
Tuition:  none


Are you equipped for EQUIP?
The Mammography Quality Standards Act (MQSA) has increased the overall effectiveness of mammography in early detection but image quality (IQ) remains the most cited cause of accreditation and certification failure. The goal of Enhancing Quality Using the Inspection Program (EQUIP) is to ensure every certified facility has a process in place to regularly monitor and control image quality.

This webinar will provide:  

  • Breast Center Directors with concrete steps towards EQUIP compliance
  • Lead Interpreting Physicians (LIP) with clear guidance on navigating EQUIP to meet clinical image and quality control mandates
  • Interpreting Physicians with a review of EQUIP expectations to prepare for IQ reviews
  • Radiologic Technologists with an understanding of how EQUIP IQ reviews will validate and/or improve their imaging skills

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Describe the concepts of the EQUIP criteria
  • Identify how the EQUIP requirements will affect Certified Mammography Centers
  • Develop methods for efficiently meeting the EQUIP criteria
  • Describe automated vs manual methods to meet and reduce the burden of EQUIP

Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials. For more information go to

Radiologic Technologist Continuing Education
This program has been approved by the Association for Medical Imaging Management (AHRA) for 1.0 hour of ARRT Category A continuing education credit. This course has been approved for CRA renewal credit under the AM, OM, and CI domains.


How to Participate
There are no fees or prerequisites to participate in this program.

  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive Credit

  • Log-in to your account at
  • View the entire educational activity session. At the conclusion of the lecture, close the recording window.
  • Return to the course in your account at
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at

Bonnie Rush is President of Breast Imaging Specialists (BIS), San Diego, CA, a consulting and education company. Ms. Rush has more than 30 years’ experience as a mammographer and obtained advanced certification in Quality Management. Bonnie is a noted educator, consultant, lecturer, and writer with long-term experience in regulatory compliance.

In 2000, Ms. Rush self-published the MQSA (Mammography Quality Standards Act) Made Easy – Understanding and Implementing the Facility-Based Final Regulations, which she updates regularly. This guide has won acclaim and was described as “an important contribution to the mammography communitya quick, accurate, thorough, and easily understood way to access the information necessary to remain in compliance with regulations” (Joanie Wilmot, RT(R)(M) in AuntMinnie, August 8, 2005).

Ms. Rush has affiliated with multiple professional societies, including the Society of Breast Imaging (SBI). Some of her past national volunteer activities included the American Registry of Radiologic Technologists (ARRT) Mammography Examination Committee, National Consortium of Breast Centers Conference Planning Committee, and American Society of Radiologic Technologists (ASRT) Mammography Practice Standards. In her state of California, she was the first Director-at-Large in Mammography for the California Society of Radiologic Technologists (CSRT). Locally she founded the Mammography Society of San Diego and the first facility low-cost mammography screening program, as well as serving on the planning committee of a state/county mammography screening program for the underserved.

For her investment of time and passion to her profession, Ms. Rush was acknowledged in a 2009 ASRT Scanner article titled Working Wonders.

Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.

Bonnie Rush, RT(R)(M)(QM), has received consulting fees from Volpara Solutions.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CHCP
Linda McLean, MS 
Victoria Phoenix, BS           
Jan Schultz, MSN, RN, CHCP
Judi Smelker-Mitchek, MBA, MSN, RN                    

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
For questions regarding this program, please contact ICPME:
Phone: 607-257-5860 X10

Jointly provided by


This activity is supported by an independent educational grant from Volpara Solutions.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.